In this study presented at the American Society of Hematology Annual Meeting and Exhibition (ASH 2021), the authors compared the experience in 5 different age groups on the amount of information provided, how well the information was understood, and topics on which patients and caregivers needed more information.
This article aims to help provide guidance because knowing which vaccinations to get can be confusing. This article will lay out the current United States national recommendations to help you make the proper choices.
As new and better treatments are developed to treat Chronic Lymphocytic Leukemia, and Small Lymphocytic Lymphoma (CLL/SLL), testing for subtypes of the disease is becoming more important for prognosis and selection of the best treatment options.
As the immune system is complex, so is testing. The best testing for antigens is to isolate a protein large enough to be antigenic and specific enough so that it is only found in that one situation. You can choose a test for the presence of active inflammation
This article will repeat some of the earlier material, but you can still go back and reread them from past CLL Society Tribune editions, Introduction of Immunity Part 1 and Part 2. Let us put together all the factoids from the first two articles and see if we can
Join CLL Society for this important Ed Forum to learn the basics about testing across the span of your CLL journey. At the time of diagnosis, find out which tests should be performed, which might be avoided, and why. Before starting your first treatment, and prior to every subsequent
In this paper presented at ASCO 2021 by Alrawashdh et al, we learn about historical survival trends for CLL patients over the 22 years between 1985 and 2017.